Revolutionizing Manufacturing Flexibility for Rare Disorders: A Model of Speed and Adaptability
Time: 3:45 pm
day: Day One PM
Details:
- Critical to accelerating gene therapies for patients with rare diseases is innovative development and manufacturing strategies, and speed-to-market at sustainable cost, and addressing the current complexity and cost of manufacturing processes and infrastructure
- Proposing a new model where the needs of manufacturing infrastructure, processes, and application of expertise are tailored to the specific needs of the pipeline lifecycle – fit-for-purpose, fit-for-phase, and cost-effective infrastructure support and scientific expertise
- We enable the acceleration of advanced therapy development and manufacturing across geographies with optimization of resource utilization and flexibility
